The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcomes of patients with HER2+ breast cancer with small-size residual disease (≤ypT1) in the absence of pathological response after trastuzumab-based neoadjuvant chemotherapy and without adjuvant T-DM1: A monocentric retrospective study.
 
Ludovic Doucet
Consulting or Advisory Role - Novartis; Pfizer; Takeda
Travel, Accommodations, Expenses - AstraZeneca; BMSi; MSD; Takeda
 
Camille Moreau-Bachelard
No Relationships to Disclose
 
Carole Gourmelon
No Relationships to Disclose
 
Marie Robert
No Relationships to Disclose
 
Dominique Berton
No Relationships to Disclose
 
Emmanuelle Bourbouloux
Consulting or Advisory Role - Amgen
 
Catherine Guerin
No Relationships to Disclose
 
Cyriac Blonz
No Relationships to Disclose
 
Nicole Andrieux
No Relationships to Disclose
 
Mario Campone
Honoraria - Lilly; Novartis
Consulting or Advisory Role - Abbvie (Inst); Accord Healthcare (Inst); AstraZeneca/MedImmune (Inst); Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Sandoz-Novartis (Inst); Sanofi (Inst); SERVIER (Inst)
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer
Other Relationship - Roche
 
Jean-Sebastien Frenel
Consulting or Advisory Role - AstraZeneca; BioCad; Daiichi Sankyo; Lilly; Novartis; Pfizer; Roche; Tesaro